FDA-Inspected Site

Sanjeev Puri, Clinical Investigator

2 FDA inspections are on record for Sanjeev Puri, Clinical Investigator in Rock Island, United States.

483· Form 483 issued

Rock Island, United States · Last updated August 15, 2026

Overview

  • 2 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2018-12-14.

At a glance

Inspections

2

Form 483s

2

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
10 Dec 2018 – 14 Dec 2018Human Drugs483On file
14 Sep 2015 – 1 Oct 2015Human Drugs483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

1 Oct 2015
21 CFR 312.62(b)

Case history records- inadequate or inadequate

Cited by Jennifer C Adams, Jennifer C Johnson

1 Oct 2015
21 CFR 312.64(b)

Safety reports

Cited by Jennifer C Adams, Jennifer C Johnson

1 Oct 2015
21 CFR 50.20

Circumstances of obtaining consent

Cited by Jennifer C Adams, Jennifer C Johnson

1 Oct 2015
21 CFR 312.60

FD-1572, protocol compliance

Cited by Jennifer C Adams, Jennifer C Johnson

1 Oct 2015
21 CFR 312.66

Initial and continuing review

Cited by Jennifer C Adams, Jennifer C Johnson

Investigators

FDA investigators tied to this site in the record.

Corey K Reno1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 312.64(b)Cited across public-safe Form 483 observations2x
21 CFR 312.60Cited across public-safe Form 483 observations1x
21 CFR 312.62(b)Cited across public-safe Form 483 observations1x
21 CFR 312.66Cited across public-safe Form 483 observations1x
21 CFR 50.20Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Sanjeev Puri, Clinical Investigator's 2 Form 483s

Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat